Overview

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the protocol is to evaluate the long-term safety of pregabalin in patients with partial seizures.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin